Misawa S, Horiike S, Taniwaki M, Abe T, Takino T
Cancer Genet Cytogenet. 1986 Aug;22(4):319-29. doi: 10.1016/0165-4608(86)90024-5.
Prefixation treatment of cultured human bone marrow cells with a DNA intercalating agent, ethidium bromide (EBr), induced a dose- and time-related elongation of chromosomes. When compared with EBr-free cultures, a 2.9-fold increase in the yield of early mitotic cells with more than 400 bands per haploid set of chromosomes was achieved by simply adding 10 micrograms/ml of EBr during the last 2 hours of culture. The proportion of early mitotic cells was equal to that obtained in methotrexate synchronized cultures. Fluorescence banding methods using base composition specific agents actinomycin D/DAPI for AT base pairs and chromomycin A3/distamycin A for GC suggested that EBr does not have base specificity, because EBr did not alter the banding patterns of chromosomes obtained with these staining procedures.
用DNA嵌入剂溴化乙锭(EBr)对培养的人骨髓细胞进行预固定处理,可诱导染色体出现剂量和时间相关的延长。与无EBr培养相比,在培养的最后2小时简单添加10微克/毫升的EBr,单倍体染色体组带数超过400条的早期有丝分裂细胞产量增加了2.9倍。早期有丝分裂细胞的比例与甲氨蝶呤同步培养获得的比例相当。使用针对AT碱基对的碱基组成特异性试剂放线菌素D/4',6-二脒基-2-苯基吲哚(DAPI)以及针对GC的放线菌素A3/偏端霉素A的荧光显带方法表明,EBr不具有碱基特异性,因为EBr不会改变通过这些染色程序获得的染色体带型。